Safety, PD and PK of PUR0200 in COPD Patients (QBR114877)

• Research type

  Research Study

• Full title

  A Phase I, 2-part, single-dose, placebo and active-controlled, dose-ranging trial to evaluate pharmacokinetics, pharmacodynamics, safety, and tolerability of PUR0200 in subjects with Chronic Obstructive Pulmonary Disease (COPD).

• IRAS ID

  130397

• Contact name

  Joanne Collier

• Contact email

  jo.collier@quotientbioresearch.com

• Sponsor organisation

  Pulmatrix, Inc

• Eudract number

  2013-000958-22

• ISRCTN Number

  to be applied for

• REC name

  Wales REC 2

• REC reference

  13/WA/0149

• Date of REC Opinion

  17 May 2013

• REC opinion

  Further Information Favourable Opinion